Paraoxonase/Arylesterase Activity of Serum Paraoxonase-1 and Schizophrenia: A Systematic Review and Meta-Analysis.

Antioxidants (Basel) · 2023 · PMC10451270 · PMID 37627479

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

However, the results of meta-regression and subgroup analyses suggest that such differences may be significant in subgroups of patients with schizophrenia, particularly older patients with relatively low HDL–cholesterol concentrations.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.